Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Norn Ventures is a specialist healthcare investment platform offering access to a curated pipeline of high-growth, next-generation healthcare businesses. With a strong track record and an experienced leadership team, the fund targets superior risk-adjusted returns over an eight-year term.
This opportunity is designed for institutional and qualified private investors seeking exposure to early- and growth-stage healthtech, medtech, and biopharma companies. The portfolio is built around commercial traction, strong IP, and global market relevance—positioning it to benefit from long-term shifts in healthcare innovation worldwide.
Fund Size: £100M
Sector: Healthcare Innovation, HealthTech,
MedTech, Biopharma
Stage: Live Raise
Investment Type: Growth Equity
Distribution: Official Distributor – Aldridge Ritchie Capital Ltd
Led by a team of experienced operators with proven exits across the healthtech space, Norn Ventures brings deep sector insight and a track record of identifying standout early-stage businesses. The leadership’s commercial, clinical, and strategic knowledge shapes the portfolio at every level.
With access to proprietary deal flow across the UK, Europe, and North America, Norn Ventures curates opportunities that rarely reach open markets. Every company is vetted for market fit, scalability, and alignment with the fund’s long-term vision.
A structured investment committee and a comprehensive risk framework guide every decision. This ensures discipline, accountability, and alignment with investor interests—building confidence at every stage of the fund’s lifecycle.
The fund is strategically diversified across digital health, diagnostics, therapeutics, and AI-powered care. This approach spreads risk while capturing upside across complementary high-growth areas within global healthcare innovation.
Norn Ventures is positioned to capitalise on seismic shifts in healthcare delivery. As health systems worldwide face increasing pressure to innovate, this fund is built to back the technologies, teams, and tools that will define the next decade.
The fund is led by a senior team with deep roots in healthcare, finance, and technology. Their combined experience across founding, scaling, and exiting businesses ensures both operational insight and investment discipline.
Norn Ventures is structured to offer institutional-grade exposure to the healthcare innovation space through a disciplined, growth-focused investment model. With a defined fund term and robust governance, the vehicle is designed to provide investors with both clarity and confidence. Our strategy targets scalable ventures across MedTech, Biopharma, and AI-driven health, supported by an experienced operating team and a network of co-investors. The fund is suitable for qualified investors seeking strategic access to a high-growth, impact-driven sector with global relevance.
This opportunity is only available to qualified, professional, or sophisticated investors. Capital is at risk. Past performance is not indicative of future returns.
Minimum Investment: £1,000,000
Fund Term: 8 Years
Target Net IRR: 18–22%
Structure: Limited Partnership
Eligible Investors: Qualified, Sophisticated, or Professional Investors Only
Geographic Focus: UK, Europe, and North America
Copyright © 2025 Aldridge Ritchie Capital - All Rights Reserved.